Select Page
CytoDyn HIV Justification Report: Guidance From FDA

CytoDyn HIV Justification Report: Guidance From FDA

The U.S FDA (Food and Drug Administration) has provided CytoDyn with guidance on its recent HIV BLA dose justification report, a crucial part of the company’s resubmission for its Biologics License Application (BLA) for HIV. CytoDyn is known for specializing in...
FDA Clearance: Syntr Health Technologies SyntrFuge System

FDA Clearance: Syntr Health Technologies SyntrFuge System

Syntr Health Technologies has been granted clearance from the US FDA (Food and Drug Administration) for their SyntrFuge System for surgical use when transferring a patient’s adipose (fat) tissue. Syntr Health Technologies, a medical device company that focuses on the...
Novartis begins Zolgensma study after FDA’s hold lifts

Novartis begins Zolgensma study after FDA’s hold lifts

Aiming to expand the use of Zolgensma, Novartis has announced the launch of a new phase three study following the FDA’s decision to remove restrictions and partial clinical trial hold. Novartis plans to evaluate the use of Zolgensma to treat patients (aged 2-18) for...